Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
This study has been completed.
Study NCT00044291   Information provided by Intarcia Therapeutics
First Received: August 23, 2002   Last Updated: August 21, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Neoplasms
Neoplasms, Hormone-Dependent
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
atamestane
toremifene
letrozole
aromatase inhibition
hormone therapy
endocrine therapy
antiestrogen therapy
Additional drug interventions recognized in this trial
Estrogen Antagonists
Estrogen Receptor Modulators
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Bone Density Conservation Agents
Enzyme Inhibitors
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Selective Estrogen Receptor Modulators
Therapeutic Uses
Sponsors listed in this trial
Intarcia Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services